A randomized, double-blind, 12-week study to evaluate the efficacy of ThermoProfen in the treatment of patients with mild to moderate pain associated with osteoarthritis of the knee (ZMK-301)

Trial Profile

A randomized, double-blind, 12-week study to evaluate the efficacy of ThermoProfen in the treatment of patients with mild to moderate pain associated with osteoarthritis of the knee (ZMK-301)

Completed
Phase of Trial: Phase III

Latest Information Update: 29 May 2012

At a glance

  • Drugs Ketoprofen (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors ZARS Pharma
  • Most Recent Events

    • 29 May 2012 Actual patient number chnaged from 600 to 679 as reported by ClinicalTrials.gov record.
    • 02 Oct 2008 Added September 2008 as the actual completion date based on information from ClinicalTrials.gov.
    • 02 Oct 2008 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top